More money for global AIDS effort
Executive Summary
The House passes a five-year, $50 billion reauthorization of the President's Emergency Plan for AIDS Relief April 2. In addition to supporting AIDS treatment and prevention programs, H.R. 5501 would allocate money to fight tuberculosis and malaria for fiscal 2009-2013. A similar bill was reported out by the Senate Foreign Affairs Committee March 13. Current spending on the PEPFAR program is $3 billion per year
You may also be interested in...
Congress approves global AIDS plan
The Senate votes 80-16 to renew the President's Emergency Plan for AIDS Relief in July, following support from the House earlier this year. Members agree to expand PEPFAR funds to $50 billion for the 2009-2013 fiscal years to support AIDS research and treatment efforts - a significant increase from its current $15 billion cap. One provision agreed to in the Senate would withhold 20 percent of the appropriations for the Global AIDS Fund until the State Department confirms access to financial data to monitor the use of such monies. The bill would also allocate money to fight tuberculosis and malaria (1"The Pink Sheet," April 7, 2008, In Brief)
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.